Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss
NCT03027479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2025-12-22
Summary
the aim is to study skeletal muscle metabolism alterations métaboliques associated with weight loss in women with ovarian and/or endometrial cancer according to BMI.
Conditions
- Weight Loss
- Ovarian Carcinoma
- Endometrial Carcinoma
Interventions
- OTHER
-
Samples
Blood samples, muscle biopsy, adipose tissue samples and ovarian cancer tumor sample
Sponsors & Collaborators
-
Inserm U1069 - Team Nutrition, Growth and Cancer
collaborator UNKNOWN -
University Hospital, Tours
lead OTHER
Principal Investigators
-
Lobna OULDAMER, MD, PhD · University Teaching Hospital of Tours
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2019-07-16
- Completion
- 2019-07-16
Countries
- France
Study Locations
More Related Trials
-
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
NCT06553612 ·Status: RECRUITING ·Phase: NA
-
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
NCT06019923 ·Status: RECRUITING
-
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
NCT07269574 ·Status: NOT_YET_RECRUITING
-
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195 ·Status: RECRUITING ·Phase: NA
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125
NCT02247323 ·Status: UNKNOWN
-
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
NCT04675320 ·Status: UNKNOWN
-
Evolution of the Therapeutic Care in Ovarian Cancer From 2011
NCT03275298 ·Status: SUSPENDED
-
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
NCT05047926 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
NCT05410015 ·Status: RECRUITING
-
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
NCT03976999 ·Status: RECRUITING ·Phase: NA
-
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients
NCT07039331 ·Status: RECRUITING ·Phase: NA
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Assessment of Ovarian Reserve in Female Cancer Survivors
NCT01062542 ·Status: COMPLETED
-
Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients
NCT06182917 ·Status: RECRUITING
-
Lymphadenectomy in Early Ovarian Cancer
NCT04710797 ·Status: RECRUITING ·Phase: NA
-
A Cohort Establishment Study of Total Management of Ovarian Cancer
NCT06018935 ·Status: RECRUITING
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
NCT01579812 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03010124 ·Status: RECRUITING ·Phase: NA
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
NCT00551577 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
NCT06139783 ·Status: NOT_YET_RECRUITING ·Phase: NA